Finance

Beta
Lists
H5P:FRA
Hikma Pharmaceuticals Plc
€16.79
+2.88%
(+0.47) 1D
Jun 3, 11:07:59 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for H5P...
Open
€16.30
High
€16.79
Low
€16.30
Mkt. cap
3.05B
Avg. vol.
29.00
Volume
100.00
52-wk high
€25.80
52-wk low
€13.80
No. of employees
9K
Open
€16.30
High
€16.79
Low
€16.30
Mkt. cap
3.05B
Avg. vol.
29.00
Volume
100.00
52-wk high
€25.80
52-wk low
€13.80
No. of employees
9K
News stories
From sources across the web
About Hikma Pharmaceuticals Plc
CEO-
Employees9.4K
Founded1978
Headquarters-
SectorPharmaceutical industry
Websitehikma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
829.00M
829.00M
845.50M
845.50M
Cost of goods sold
466.50M
466.50M
479.50M
479.50M
Cost of revenue
466.50M
466.50M
479.50M
479.50M
Research and development expenses
36.50M
36.50M
39.00M
39.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
139.00M
139.00M
194.00M
194.00M
Operating expense
175.50M
175.50M
229.00M
229.00M
Total operating expenses
642.00M
642.00M
708.50M
708.50M
Operating income
187.00M
187.00M
137.00M
137.00M
Other non operating income
-
-
-6.00M
-6.00M
EBT including unusual items
147.50M
147.50M
112.00M
112.00M
EBT excluding unusual items
169.00M
169.00M
104.00M
104.00M
Income tax expense
27.50M
27.50M
28.50M
28.50M
Effective tax rate
18.64%
18.64%
25.45%
25.45%
Other operating expenses
-
-
-4.00M
-4.00M
Net income
119.00M
119.00M
82.00M
82.00M
Net profit margin
14.35%
14.35%
9.70%
9.70%
Earnings per share
-
-
-
-
Interest and investment income
2.00M
2.00M
1.00M
1.00M
Interest expense
-20.00M
-20.00M
-22.50M
-22.50M
Net interest expenses
-18.00M
-18.00M
-21.50M
-21.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
238.00M
238.00M
183.00M
183.00M
Gain or loss from assets sale
-
-
500.00K
500.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer